Companies Dominating the Leuprolide Acetate Market
- Ferring B.V.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Sun Pharmaceutical Industries Ltd.
- Beijing Biote Pharmaceutical Co., Ltd.
- Anhui Anke Bioengineering (Group) Co., Ltd.
- AbbVie Inc.
- Merck & Co., Inc.
- Taj Pharmaceuticals Limited.
- Zydus Group
- Cipla Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
2025 Leuprolide Acetate Market is evaluated at USD 2.43 billion.
The global leuprolide acetate market size was over USD 2.3 billion in 2024 and is forecast to experience a CAGR of over 6.8%, reaching USD 5.41 billion by 2037.
North America is forecasted to amass USD 2.16 billion by 2037, fueled by rising healthcare spending, improving medical access, and the diagnosis of diseases such as prostate cancer and fertility issues.
The major players in the market are Ferring B.V., Sun Pharmaceutical Industries Ltd., Beijing Biote Pharmaceutical Co., Ltd., Anhui Anke Bioengineering (Group) Co., Ltd., AbbVie Inc., Merck & Co., Inc., Taj Pharmaceuticals Limited., Zydus Group, Cipla Inc.
